Kala Pharmaceuticals, Inc. (KALA) News

Kala Pharmaceuticals, Inc. (KALA): $16.54

-0.11 (-0.66%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter KALA News Items

KALA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

KALA News Highlights

  • For KALA, its 30 day story count is now at 10.
  • Over the past 15 days, the trend for KALA's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • TOP, DRUG and HUGE are the most mentioned tickers in articles about KALA.

Latest KALA News From Around the Web

Below are the latest news stories about KALA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate KALA as an investment opportunity.

7 Top Short-Squeeze Candidates to Watch in February

For those that want to zig while others zag, these heavily targeted stocks represent the short-squeeze candidates to watch this month.

Josh Enomoto on InvestorPlace | February 1, 2023

Shareholders are distrustful How to React (Brief breakdown): Kala Pharmaceuticals, Inc. (NASDAQ:KALA 20.98%), ProQR Therapeutics N.V. (NASDAQ:PRQR 3.64%)

KALA has seen its SMA50 which is now 53.78%. In looking the SMA 200 we see that the stock has seen a 7.40%. PRQR has seen its SMA50 which is … The post Shareholders are distrustful How to React (Brief breakdown): Kala Pharmaceuticals, Inc. (NASDAQ:KALA 20.98%), ProQR Therapeutics N.V. (NASDAQ:PRQR 3.64%) appeared first on Stocks Equity .

Stock Equity | January 27, 2023

Kala Pharmaceuticals Inc. (NASDAQ:KALA) Jumps 20.98%, But Additional Rally May Be Imminent

In last trading session, Kala Pharmaceuticals Inc. (NASDAQ:KALA) saw 3.03 million shares changing hands with its beta currently measuring -1.58. Company’s recent per share price level of $18.97 trading at $3.29 or 20.98% at ring of the bell on the day assigns it a market valuation of $27.89M. That closing price of KALA’s stock is … Kala Pharmaceuticals Inc. (NASDAQ:KALA) Jumps 20.98%, But Additional Rally May Be Imminent Read More »

Marketing Sentinel | January 27, 2023

KALA, THMO and KTRA among mid-day movers

Gainers: MicroAlgo (MLGO) +84%.Kala Pharmaceuticals (KALA) +35%.Qualtrics International XM +32%.Qurate Retail (QRTEB) +31%.Scilex Holding SCLX +29%.World Acceptance WRLD +23%.Edible…

Seeking Alpha | January 26, 2023

Kala Pharmaceuticals, PaxMedica, Getty And Other Short Squeeze Stocks That Could Soar

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze. Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard and some other stocks to watch moving up the list. See Also: Mark Cuban''s 4 Rules For Making Money Kala Phamaceuticals (NASDAQ: KALA ): Clinical stage biopharmaceutical company Kala tops the leaderboard for the second straight week. Data shows 36.9% of the float short, up from last week’s 36.3% figure. The cost to borrow on shares is 288%, down from last week’s 378.2%. Shares of the Watertown, Massachusetts-based company recently soared after ...

Benzinga | January 23, 2023

Kala Pharmaceuticals falls after up to $40M shares sale announcement

Kala Pharmaceuticals (KALA) was down ~5% pre-market as the company entered into an open market sale agreement with Jefferies for the sale of up to $40M of shares.

Seeking Alpha | January 20, 2023

Kala Pharma (KALA) Is Considered a Good Investment by Brokers: Is That True?

The average brokerage recommendation (ABR) for Kala Pharma (KALA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Yahoo | January 19, 2023

Best Momentum Stocks to Buy for January 17th

RYAM, BUD and KALA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 17, 2022.

Yahoo | January 17, 2023

7 Long-Term Stocks to Buy and Hold Forever

Now may be the time to scoop up high-quality names that continue to trade at very favorable valuations.

Louis Navellier and the InvestorPlace Research Staff on InvestorPlace | January 10, 2023

Kala Pharmaceuticals Inc. (NASDAQ:KALA) 90.35% Above Its 52-Week Low, How Long Will It Keep Rising?

In last trading session, Kala Pharmaceuticals Inc. (NASDAQ:KALA) saw 3.68 million shares changing hands with its beta currently measuring -0.55. Company’s recent per share price level of $36.67 trading at -$5.42 or -12.88% at ring of the bell on the day assigns it a market valuation of $36.30M. That closing price of KALA’s stock is … Kala Pharmaceuticals Inc. (NASDAQ:KALA) 90.35% Above Its 52-Week Low, How Long Will It Keep Rising? Read More »

Marketing Sentinel | January 6, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.72 seconds.